Literature DB >> 34592495

Systemic cytokines, chemokines and growth factors reveal specific and shared immunological characteristics in infectious cardiomyopathies.

Eula G A Neves1, Carolina C Koh1, José L Padilha da Silva2, Lívia S A Passos3, Fernanda N A Villani4, Janete S C Dos Santos5, Cristiane A S Menezes6, Vicente R Silva7, Julia P A S Tormin7, Guilherme F B Evangelista8, Andréa Teixeira de Carvalho9, Manoel Otávio da Costa Rocha7, Bruno Nascimento7, Kenneth John Gollob10, Maria do Carmo P Nunes7, Walderez O Dutra11.   

Abstract

Heart disease is a major cause of death worldwide. Chronic Chagas cardiomyopathy (CCC) caused by infection with Trypanosoma cruzi leading to high mortality in adults, and rheumatic heart disease (RHD), resulting from infection by Streptococcus pyogenes affecting mainly children and young adults, are amongst the deadliest heart diseases in low-middle income countries. Despite distinct etiology, the pathology associated with both diseases is a consequence of inflammation. Here we compare systemic immune profile in patients with these cardiopathies, to identify particular and common characteristics in these infectious heart diseases. We evaluated the expression of 27 soluble factors, employing single and multivariate analysis combined with machine-learning approaches. We observed that, while RHD and CCC display higher levels of circulating mediators than healthy individuals, CCC is associated with stronger immune activation as compared to RHD. Despite distinct etiologies, univariate analysis showed that expression of TNF, IL-17, IFN-gamma, IL-4, CCL4, CCL3, CXCL8, CCL11, CCL2, PDGF-BB were similar between CCC and RHD, consistent with their inflammatory nature. Network analysis revealed common inflammatory pathways between CCC and RHD, while highlighting the broader reach of the inflammatory response in CCC. The final multivariate model showed a 100% discrimination power for the combination of the cytokines IL-12p70, IL-1Ra, IL-4, and IL-7 between CCC and RHD groups. Thus, while clear immunological distinctions were identified between CCC and RHD, similarities indicate shared inflammatory pathways in these infectious heart diseases. These results contribute to understanding the pathogenesis of CCC and RHD and may impact the design of immune-based therapies for these and other inflammatory cardiopathies that may also share immunological characteristics.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chagas disease; Inflammation; Pathology; Rheumatic heart disease; Systemic immune profile

Mesh:

Substances:

Year:  2021        PMID: 34592495      PMCID: PMC8546740          DOI: 10.1016/j.cyto.2021.155711

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  61 in total

1.  Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.

Authors:  Juliana A S Gomes; Lilian M G Bahia-Oliveira; Manoel Otávio C Rocha; Solange C U Busek; Mauro M Teixeira; João Santana Silva; Rodrigo Correa-Oliveira
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data.

Authors:  Sofie Van Gassen; Britt Callebaut; Mary J Van Helden; Bart N Lambrecht; Piet Demeester; Tom Dhaene; Yvan Saeys
Journal:  Cytometry A       Date:  2015-01-08       Impact factor: 4.355

3.  Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015.

Authors:  David A Watkins; Catherine O Johnson; Samantha M Colquhoun; Ganesan Karthikeyan; Andrea Beaton; Gene Bukhman; Mohammed H Forouzanfar; Christopher T Longenecker; Bongani M Mayosi; George A Mensah; Bruno R Nascimento; Antonio L P Ribeiro; Craig A Sable; Andrew C Steer; Mohsen Naghavi; Ali H Mokdad; Christopher J L Murray; Theo Vos; Jonathan R Carapetis; Gregory A Roth
Journal:  N Engl J Med       Date:  2017-08-24       Impact factor: 91.245

Review 4.  Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association.

Authors:  Maria Carmo Pereira Nunes; Andrea Beaton; Harry Acquatella; Caryn Bern; Ann F Bolger; Luis E Echeverría; Walderez O Dutra; Joaquim Gascon; Carlos A Morillo; Jamary Oliveira-Filho; Antonio Luiz Pinho Ribeiro; Jose Antonio Marin-Neto
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

5.  Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression.

Authors:  C A S Menezes; M O C Rocha; P E A Souza; A C L Chaves; K J Gollob; W O Dutra
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

6.  Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy.

Authors:  Edecio Cunha-Neto; Luciana G Nogueira; Priscila C Teixeira; Rajendranath Ramasawmy; Sandra A Drigo; Anna Carla Goldberg; Simone G Fonseca; Angelina M Bilate; Jorge Kalil
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

7.  Granulocyte colony-stimulating factor (G-CSF) plays an important role in immune complex-mediated arthritis.

Authors:  Anne D Christensen; Claus Haase; Andrew D Cook; John A Hamilton
Journal:  Eur J Immunol       Date:  2016-02-29       Impact factor: 5.532

8.  Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease.

Authors:  Paulo Marcos Matta Guedes; Fredy Roberto Salazar Gutierrez; Grace Kelly Silva; Renata Dellalibera-Joviliano; Gerson Jhonatan Rodrigues; Lusiane Maria Bendhack; Anis Rassi; Anis Rassi; André Schmidt; Benedito Carlos Maciel; José Antonio Marin Neto; João Santana Silva
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

9.  Growth factor PDGF-BB stimulates cultured cardiomyocytes to synthesize the extracellular matrix component hyaluronan.

Authors:  Urban Hellman; Linus Malm; Li-Ping Ma; Göran Larsson; Stellan Mörner; Michael Fu; Anna Engström-Laurent; Anders Waldenström
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

10.  Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas' Heart Disease: Antagonistic Participation of CCR1+ and CCR5+ Cells in Chronic Chagasic Cardiomyopathy.

Authors:  Angelica Martins Batista; Lucia Elena Alvarado-Arnez; Silvia Marinho Alves; Gloria Melo; Isabela Resende Pereira; Leonardo Alexandre de Souza Ruivo; Andrea Alice da Silva; Daniel Gibaldi; Thayse do E S Protásio da Silva; Virginia Maria Barros de Lorena; Adriene Siqueira de Melo; Ana Karine de Araújo Soares; Michelle da Silva Barros; Vláudia Maria Assis Costa; Cynthia C Cardoso; Antonio G Pacheco; Cristina Carrazzone; Wilson Oliveira; Milton Ozório Moraes; Joseli Lannes-Vieira
Journal:  Front Immunol       Date:  2018-04-11       Impact factor: 7.561

View more
  2 in total

1.  T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies.

Authors:  Eula G A Neves; Carolina C Koh; Thaiany G Souza-Silva; Lívia Silva Araújo Passos; Ana Carolina C Silva; Teresiama Velikkakam; Fernanda Villani; Janete Soares Coelho; Claudia Ida Brodskyn; Andrea Teixeira; Kenneth J Gollob; Maria do Carmo P Nunes; Walderez O Dutra
Journal:  Front Cardiovasc Med       Date:  2022-02-02

2.  Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach.

Authors:  Joseli Lannes-Vieira
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-23       Impact factor: 2.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.